Performance of Two Silicone Hydrogel Toric Contact Lenses

Inclusion Criteria: * Be between 18 and 45 years of age. * Sign Written Informed Consent (See separate document). * Be an existing successful daily wear toric soft contact lens. * Require a visual correction in both eyes (monovision or uniocular fitting is NOT allowed). * Does not require presbyopic correction (can read J1 @ normal reading distance). * Have a sphere requirement in the range -1.00 and -5.00D (-5.25D refractive) * Have refractive astigmatism between 0.75D and 2.50D in both eyes. * Achieve visual acuity of 20/30 or better in each eye with spherical distance correction. * Have normal eyes with no evidence of abnormality or disease. For the purposes of this study a normal eye is defined as one having: * No amblyopia. * No evidence of lid abnormality or infection. * No conjunctival abnormality or infection. * No clinically significant slit lamp findings (i.e. stromal edema, vascularisation, infiltrates or abnormal opacities). * No other active ocular disease. Exclusion Criteria: * Requires concurrent ocular medication. * Clinically significant (Grade 3 or 4) corneal stromal haze, corneal vascularisation, tarsal abnormalities, bulbar hyperemia, limbal hyperemia, or any other abnormality of the cornea that would contraindicate contact lens wear. * Corneal staining Grade 3 in more than one region. * Has had refractive surgery. Has had eye injury/surgery within 8 weeks immediately prior to enrolment for this study. * Abnormal lacrimal secretions. * Pre-existing ocular irritation that would preclude contact lens fitting. * Keratoconus or other corneal irregularity. * Polymethyl methacrylate (PMMA) or Rigid Gas Permeable (RGP) lens wear in the previous 8 weeks * Extended lens wear in last 3 months. * Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear. * Diabetic. * Infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV). * Pregnancy, lactating or planning a pregnancy at the time of enrolment. * Participation in any concurrent clinical trial or in last 60 days.